GSA Capital Partners »

Aclaris Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 1.6M 1.05
2023-09-30 $260k 38k 6.85
2023-06-30 $865k 84k 10.36
2023-03-31 $262k 32k 8.10